Benzinga | Dec 29, 2020 07:09AM EST

Raymond James Downgrades Arcturus Therapeutics to Market Perform

Raymond James analyst Steven Seedhouse downgrades Arcturus Therapeutics (NASDAQ:ARCT) from Outperform to Market Perform.